Guang-Biao Zhou Selected Research

Guang-Biao Zhou Research Topics

Disease

40	Neoplasms (Cancer) 04/2024 - 02/2005
21	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2011
12	Leukemia 08/2012 - 01/2005
11	Acute Promyelocytic Leukemia 08/2012 - 01/2005
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2012
10	Carcinogenesis 01/2022 - 06/2015
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 02/2005
3	Multiple Myeloma 12/2013 - 01/2011
3	Carcinoma (Carcinomatosis) 09/2012 - 03/2009
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2012 - 02/2005
2	Genomic Instability 04/2024 - 07/2015
2	Disease Progression 01/2019 - 01/2005
2	Adenocarcinoma of Lung 01/2018 - 11/2017
2	Hematologic Neoplasms (Hematological Malignancy) 04/2012 - 06/2011
2	Body Weight (Weight, Body) 07/2009 - 04/2007
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2024
1	Lymphoma (Lymphomas) 05/2023
1	COVID-19 11/2022
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	Dizziness (Lightheadedness) 11/2021
1	Thalassemia 11/2021
1	Exanthema (Rash) 11/2021
1	Fatigue 11/2021
1	Fever (Fevers) 11/2021
1	Pharyngitis (Sore Throat) 11/2021
1	Ovarian Neoplasms (Ovarian Cancer) 02/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 04/2024 - 02/2005
7	SmokeIBA 01/2022 - 07/2015
6	CarcinogensIBA 11/2021 - 07/2015
6	Oncogene Proteins (Oncogene Protein)IBA 03/2020 - 01/2007
6	ArsenicIBA 04/2012 - 01/2005
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2011 - 01/2005
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
5	Imatinib Mesylate (Gleevec)FDA Link 02/2012 - 01/2005
4	Transcription Factors (Transcription Factor)IBA 11/2022 - 01/2007
4	Cisplatin (Platino)FDA LinkGeneric 02/2018 - 01/2012
4	Coal (Coals)IBA 09/2016 - 06/2015
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
3	Benzo(a)pyreneIBA 11/2021 - 11/2015
3	ErbB Receptors (EGF Receptor)IBA 03/2020 - 01/2012
3	celastrolIBA 01/2019 - 04/2014
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 02/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 07/2015
2	Adenosine Triphosphate (ATP)IBA 04/2024 - 01/2012
2	LigandsIBA 01/2022 - 01/2021
2	CytokinesIBA 01/2022 - 07/2015
2	ChemokinesIBA 01/2021 - 07/2015
2	UbiquitinIBA 03/2020 - 01/2016
2	largazoleIBA 01/2020 - 10/2013
2	Therapeutic UsesIBA 01/2019 - 06/2011
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2019 - 02/2014
2	Small Interfering RNA (siRNA)IBA 10/2018 - 01/2011
2	6-O-angeloylprenolinIBA 01/2017 - 01/2011
2	Ligases (Synthetase)IBA 01/2016 - 10/2015
2	AA005IBA 04/2014 - 01/2012
2	bigelovinIBA 12/2013 - 06/2009
2	Gefitinib (Iressa)FDA Link 09/2012 - 01/2012
2	oridoninIBA 03/2012 - 04/2007
2	Tyrosine Kinase InhibitorsIBA 02/2012 - 01/2007
2	Arsenic Trioxide (Trisenox)FDA Link 03/2009 - 01/2007
2	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2007 - 01/2005
1	Glucose (Dextrose)FDA LinkGeneric 02/2024
1	Monoclonal AntibodiesIBA 05/2023
1	Immunoglobulin G (IgG)IBA 05/2023
1	Immunoglobulins (Immunoglobulin)IBA 05/2023
1	Angiotensin-Converting Enzyme 2IBA 11/2022
1	QuinolonesIBA 03/2022
1	ProdrugsIBA 03/2022
1	ParaffinIBA 01/2022
1	CalciumIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	KynurenineIBA 01/2022
1	R-Type Calcium Channels (R-Type Calcium Channel)IBA 01/2022
1	CXC ChemokinesIBA 01/2022
1	AntibodiesIBA 01/2022
1	Dextrans (Dextran)FDA Link 11/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2021
1	AzoxymethaneIBA 11/2021
1	Thalidomide (Thalomid)FDA Link 11/2021
1	GlobinsIBA 11/2021
1	Ursolic AcidIBA 11/2020
1	Trace Elements (Biometals)IBA 12/2019
1	ResveratrolIBA 01/2019
1	pembrolizumabIBA 01/2019
1	Ellagic AcidIBA 01/2019
1	PolyphenolsIBA 01/2019
1	fu-yuanIBA 02/2018
1	Complementary DNA (cDNA)IBA 01/2018
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2017
1	MethyltransferasesIBA 01/2017
1	GuanineIBA 01/2017
1	CytosineIBA 01/2017
1	Phosphates (Orthophosphate)IBA 01/2017
1	Long Noncoding RNAIBA 09/2016
1	Y-Box-Binding Protein 1IBA 09/2016

Therapy/Procedure

18	Therapeutics 04/2024 - 01/2005
1	Immunotherapy 01/2019